 Table 1 
No Evidence of an Association between the APOBEC3B

Deletion Polymorphism and Susceptibility to HIV Infection and AIDS in Japanese and Indian Populations
To the Editor-The apolipoprotein B messenger RNA (mRNA) editing enzyme, catalytic polypeptide-like (APO-BEC) family of genes for antiviral cytidine deaminases plays crucial roles in the intracellular defense mechanism against human immunodeficiency virus type 1 (HIV-1) [1] [2] [3] . APOBEC3B, a member of the APOBEC gene family and a 29.5-kb deletion that occurs between exon 5 of APOBEC3A and exon 8 of APOBEC3B, is commonly observed in the human population [4] . This deletion results in the complete loss of the APOBEC3B coding region in the genome [4] .
It was reported by An et al [5) that individuals who are homozygous for the deletion allele of APOBEC3B had an increased the risk of HIV-1 infection and AIDS progression; this conclusion was based on studies of 2 ethnic populations, European Americans and African Americans. However, in their study the homozygotes were not observed in 724 European American control subjects and the distribution of genotypes among these control subjects significantly departed from the Hardy-Weinberg equilibrium. Thus, further replication studies are required to clarify the impact of APOBEC3B deletion on susceptibility to HIV infection and AIDS. Because the frequencies of the APOBEC3B deletion allele were found to be ∼0.075 and ∼0.039 in European Americans and African Americans, respectively, the expected numbers of individuals who are homozygous for the APOBEC3B deletion allele should be extremely low. On the other hand, the APOBEC3B deletion allele is more commonly observed in Asian populations [4] , which are advantageous for studying the impact of the APOBEC3B deletion allele on susceptibility to HIV infection and AIDS.
We have investigated the association between the APOBEC3B deletion allele and susceptibility to HIV infection and AIDS in samples from 2 Asian populations, Japanese and Indian, which were previously analyzed for an association with polymorphisms in tripartite motif-containing 5a [6] . We obtained no evidence to support this association. The frequencies of the APOBEC3B deletion allele and of APOBEC3B deletion allele homozygotes did not differ between HIV-1-infected subjects and control subjects in either ethnic population (Table 1 ). In addition, a meta-analysis based on the results from the study of An et al [5] and from our study showed no statistical significance for the association between the APOBEC3B deletion and susceptibility to HIV infection and AIDS. The odds ratio for the APOBEC3B deletion allele was 1.046 (95% confidence interval, 0.896-1.221; P p ), and that for APOBEC3B deletion .572 allele homozygotes was 1.223 (95% confidence interval, 0.660-2.267;
). P p .523 We also evaluated the effects of APOBEC3B deletion on chronic HIV-1 infection. Ninety-five HIV-1-infected Japanese subjects with hemophilia were divided into 2 groups on the basis of their clinical courses during follow-up period of 115 years: one group of 48 subjects who maintained their CD4 + T cell counts at у200 cells/mL without antiretroviral treatment (nonprogressors), and another group of 47 subjects who required antiretroviral treatment because of depletion of their CD4 + T cells below this level (slow progressors). When the frequencies of the APOBEC3B deletion allele and of homozygotes were compared between these 2 groups, there was no significant difference in the distribution of the allele (frequency, 0.323 in nonprogressors vs 0.277 in slow progressors) or homozygotes (frequency, 0.083 in nonprogressors vs 0.084 in slow progressors).
In addition, we found no effects of APOBEC3B deletion on HIV-1 load and CD4 + T cell count. The data for HIV-1 load were available for 75 of 95 HIV-1-infected Japanese subjects and 76 of 251 HIV-1-infected Indian subjects. No significant correlations between the APOBEC3B genotypes and HIV-1 load were observed in either the Japanese population (mean ‫ע‬ standard error [ It has been reported that APOBEC3G and APOBEC3F play major roles in the APOBEC3-mediated defense against HIV-1 infection [1] [2] [3] ; however, HIV-1 has a defense against the anti-HIV effects of APOBEC3G and APOBEC3F through the Vif-induced degradation of APOBEC3 proteins. On the contrary, APOBEC3B has been reported to be resistant against the Vif-induced degradation of APOBEC3 [2, [7] [8] [9] , which may be advantageous in the host defense against HIV-1 infection. However, the expression of APOBEC3B is usually absent in the lymphoid cells that serve as targets for HIV-1 infection [2, 9, 10] , which may be the reason that the APOBEC3B deletion was not associated with the susceptibility to HIV infection and AIDS.
In conclusion, we found that the deletion polymorphism of APOBEC3B had no effect on susceptibility to HIV infection and AIDS in Japanese or Indian populations. Further studies will be required to clarify the impact of APOBEC3B deletion on the susceptibility to HIV infection and AIDS in still other populations.
